The company is engaged in primary cell and cell line culture technology platform; More than 500 ATCC cell lines, more than 200 DSMZ cell lines and more than 50 RIKEN cell lines have been introduced. And with the domestic major preservation centers have close contact, cell line type, quality! The company has built its own cell bank with standardized management, which can provide clear cell line background, references and excellent culture conditions. The company is a domestic cell biology platform focusing on cell culture. It mainly has resuscitation and cryopreservation cell lines and cell culture related technical services, mainly providing effective technical support, technical training and after-sales services for cell life science researchers. Its cell lines are mainly from ATCC Riken, ScienCell, Invitrogen, ECACC, ACC and other cell banks, as well as the establishment of some domestic and foreign cell research institutions. With the help of a strong cell line research team and sales team, the company has formed a long-term strategic partnership for cell culture with many large general hospitals, specialized hospitals and university research institutions in China. 【 View details 】

• corporate name: Shanghai Dehai Biotechnology Co., Ltd
• Main products: Dsmz cell line, atcc cell line
• administrative division: Shanghai Huangpu
• Business scope: Dsmz cell line, atcc cell line
• Enterprise type: company with limited liability